Clinical evaluation on the pulse high-volume hemofiltration in the treatment of patients with acute respiratory distress syndrome

SHAO Min,LIU Bao,WANG Jin-quan
DOI: https://doi.org/10.3969/j.issn.1001-0025.2011.01.006
2011-01-01
Abstract:Objective:To investigate the clinical effects and safety of pulse high-volume hemofiltration as treatment on patients with acute respiratory distress syndrome(ARDS) in ICU.Methods:This was a retrospective research.Twenty-two patients with ARDS receiving pulse high-volume hemofiltration treatment in the medical ICU from Jan 2005 to Sep 2010 as group B.We also found 26 matching patients as control group(group A) receiving continuous normal-volume hemofiltration.The safety and efficiency of the two treatments were compared.We also compared vital signs,oxygenation index,28-day mortality,the days staying in ICU and the days of ventilation between the two groups.Results:There were no difference in 28-days mortality(19.2%vs13.6%,P>0.05)and the safety indexes(mean arterial pressure,temperatrue,respiration rate and pulse)between the two groups.But we found obvious difference in the days staying in ICU(10.6±4.5 vs 8.1±3.0,P<0.05)and the days of ventilation(8.6±3.0 vs 6.3±2.5,P<0.05)of the two groups.Conclusion:It is of great safety and high efficiency to apply pulse high-volume hemofiltration on patients with ARDS in ICU.
What problem does this paper attempt to address?